SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 and 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 15, 2001
Human Pheromone Sciences, Inc.
---------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94 -3107202
-------------------------- ------------- ---------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
84 West Santa Clara Street, Suite 720, San Jose, California 95113
- ----------------------------------------------------------- --------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (408) 938-3030
----------------
46750 Fremont Boulevard, Fremont, California 94538
--------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS
The Audit Committee of the Company authorized the termination of BDO
Seidman LLP as auditors of the Company effective June 15, 2001. The
reports of BDO Seidman LLP on the Company's financial statements for
the past two fiscal years did not contain an adverse opinion or a
disclaimer of opinion and were not qualified or modified as to
uncertainty, audit scope, or accounting principles.
In connection with the audits of the Company's financial statements for
each of the two fiscal years ended December 31, 2000, and in the
subsequent interim period through the date hereof, there were no
disagreements with BDO Seidman LLP on any matters of accounting
principles or practices, financial statement disclosure, or auditing
scope and procedures which, if not resolved to the satisfaction of BDO
Seidman LLP would have caused BDO Seidman LLP to make reference to the
matter in their report. The Company has requested BDO Seidman LLP to
furnish it a letter addressed to the Commission stating whether it
agrees with the above statements. A copy of that letter, dated June 20,
2001, is filed as Exhibit 7.1 to this Form 8-K.
ITEM 7 FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
Exhibit 7.1 - Letter from BDO Seidman LLP pursuant to Item 304 (a) (3)
of Regulation S-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
By: /s/ William P. Horgan
------------------------------------------
William P. Horgan, Chief Executive Officer